Amylyx Pharmaceuticals, Inc. (AMLX)
12.56
-0.54
(-4.12%)
USD |
NASDAQ |
Dec 15, 16:00
12.70
+0.14
(+1.11%)
Pre-Market: 09:22
Amylyx Pharmaceuticals EPS Diluted (Quarterly): -0.3684 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Humana, Inc. | 1.615 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -34.39M |
| Total Expenses (Quarterly) | 34.39M |
| Enterprise Value | 1.041B |
| Earnings Yield | -14.33% |
| Normalized Earnings Yield | -14.33 |